Myocardial Infarction Acute Heart Failure Left Sided clinical trials

Explore recruiting myocardial infarction acute heart failure left sided clinical trials.

Recruiting myocardial infarction acute heart failure left sided studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Myocardial Infarction Acute Heart Failure Left Sided trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase 2, Multicenter, Randomized, Parallel, 3-arm, Placebo-controlled Study to Assess Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction (≤ 45%) After Myocardial Infarction (HF-REVERT)

Poland, Spain, Czechia, Greece, Netherlands, Germany +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Myocardial Infarction Acute Heart Failure Left Sided trials by city

Myocardial Infarction Acute Heart Failure Left Sided clinical trials

Recruiting myocardial infarction acute heart failure left sided studies right now

Effect at 3 Months of Early Empagliflozin Initiation in Cardiogenic Shock Patients on Mortality, Rehospitalization, Left Ventricular Ejection Fraction and Renal Function.

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

Also recruiting in Europe

Phase 2, Multicenter, Randomized, Parallel, 3-arm, Placebo-controlled Study to Assess Efficacy and Safety of CDR132L in Patients with Reduced Left Ventricular Ejection Fraction (≤ 45%) After Myocardial Infarction (HF-REVERT)

Myocardial Infarction Acute Heart Failure Left Sided trials by city

Other conditions